What if a surgeon could instantly determine, mid-operation, whether a brain tumor is a deadly glioblastoma or a treatable lymphoma that demands an entirely different approach? This question isn’t just a thought experiment—it’s a life-or-death reality for thousands of patients undergoing brain
Imagine a promising biotech company, poised to revolutionize treatment for a debilitating skin condition, only to see its stock value obliterated overnight by disappointing trial results. This is the reality for Moonlake Immunotherapeutics, a Swiss-based firm that witnessed an 80% plunge in its
Imagine a world where a single protein could unlock the secrets to halting leukemia, a devastating blood cancer that claims countless lives each year, and bring hope to millions through groundbreaking advancements. This is not a distant dream but a tangible possibility with the discovery of
Imagine a world where a single injection in the arm could halt the progression of a debilitating eye condition like age-related macular degeneration (AMD), a disease that affects nearly 200 million people globally and stands as a leading cause of vision loss among those over 60. This vision is
In an era where the pharmaceutical industry grapples with skyrocketing costs and lengthy timelines for drug development, a groundbreaking approach is emerging from a biotechnology innovator based in Fukuoka, Japan. With the traditional process often taking over a decade and billions of dollars to
For countless families touched by Huntington’s disease (HD), a genetic neurodegenerative disorder with no cure or disease-modifying treatments, the struggle against an inevitable decline has been a heartbreaking reality, but a beacon of hope emerged on September 24, 2025. On that date, uniQure
